Abstract
In chronically prepared guinea pigs, we investigated the time course of botulinum toxin A's (Bot A) effect on the blink reflex by monitoring lid movements and EMG activity prior to and after Bot A injection into the orbicularis oculi muscle (OOemg), or after nerve crush of the zygomatic nerve. We correlated these alterations with the morphological changes of the orbicularis oculi (lid-closing) muscles of the same animals. After Bot A treatment there was a profound reduction of OOemg activity and blink amplitudes as well as a slowing of maximum blink down-phase velocity. Blink up-phases, however, remained unchanged. Gradual recovery of OOemg magnitude and blink amplitude started around day 6; a functioning blink reflex appeared on day 21, and full recovery of blink amplitude occurred by day 42. Crushing the zygomatic branch of the facial nerve produced similar changes in blink parameters, but recovery was much more rapid (15 days) than for Bot A-treated guinea pigs. The morphological analysis demonstrated that Bot A produced a denervation-like atrophy in the orbicularis oculi. No fiber type-specific alterations were noted, and all muscle fiber types ultimately recovered, with no long-standing consequences of the transient denervation. Our findings support the notion that functional recovery was the result of preterminal and terminal axonal sprouting that subsequently re-establishes functional innervation. Moreover, differences between the present findings and those seen after injection of Bot A into the extraocular muscles strongly support the hypothesis that the composition in terms of muscle fiber type and the properties of the motor control system of a given muscle greatly influence both how the particular muscle responds to toxin injection, and how effective the toxin is in resolution of neuromuscular disorders that affect a particular muscle. The present findings were consistent with clinical observations that Bot A produces only temporary relief in patients with essential blepharospasm. It is likely that the efficacy of Bot A in treatment of blepharospasm could be improved by using agents that suppress terminal sprouting. The close correspondence of the changes in blink physiology between human patients and guinea pigs after Bot A treatment demonstrate that the guinea pig is an excellent model system for testing strategies to prolong the beneficial effects of Bot A treatment in relieving lid spasms in human subjects.
Similar content being viewed by others
References
Alderson K, Holds JB, Anderson RL (1991) Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 41:1800–1805
Angaut-Petit D, Molgó J, Comella JX, Faille L, Tabti N (1990) Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience 37:799–808
Becker W, Fuchs AF (1988) Lid-eye coordination during vertical gaze in man and monkey. J Neurophysiol 60:1227–1252
Berardelli A, Rothwell JC, Day BL, Marsden CD (1985) Pathophysiology of blepharospasm and oromandibular dystonia. Brain 108:593–608
Booth CM, Kemplay SK, Brown MC (1990) An antibody to neural cell adhesion molecule impairs motor nerve terminal sprouting in a mouse muscle locally paralysed with botulinum toxin. Neuroscience 35:85–91
Brown MC, Goodwin GM, Ironton R (1977) Prevention of motor nerve sprouting in botulinum toxin poisoned mouse soleus muscles by direct stimulation of the muscle. J Physiol 267: 42P
Brown MC, Holland RL, Hopkins WG (1981) Motor nerve sprouting. Ann Rev Neurosci 4:17–42
Capra NF, Bernanke JM, Porter JD (1991) Ultrastructural changes in the masseter muscle of Macaco fascicularis resulting from intramuscular injections of botulinum toxin type A. Arch Oral Biol 36:827–836
Duchen LW (1970) Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles. J Neurol Neurosurg Psychiatry 33:580–585
Duchen LW (1971) An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse. J Neurol Sci 14:47–60
Dutton JJ, Buckley EG (1988) Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 95:1529–1534
Edström L, Lindquist C (1973) Histochemical fiber composition of some facial muscles in the cat in relation to their contraction properties. Acta Physiol Scand 89:491–503
Evinger C, Manning KA (1988) A model system for motor learning: adaptive gain control of the blink reflex. Exp Brain Res 70:527–538
Evinger C, Shaw MD, Peck CK, Manning KA, Baker R (1984) Blinking and associated eye movements in humans, guinea pigs, and rabbits. J Neurophysiol 52:323–339
Evinger C, Horn AKE, Pellegrini JJ, Basso MA (1991a) Induction of blink reflex hyperexcitability by facial nerve damage. Neurosci Abstr 17:461
Evinger C, Manning KA, Sibony PA (1991b) Eyelid movements: mechanisms and normal data. Invest Ophthalmol Vis Sci 32:387–400
Evinger C, Basso MA, Manning KA, Sibony PA, Pellegrini JJ, Horn AKE (1993) A role for the basal ganglia in nicotinic modulation of the blink reflex. Exp Brain Res 92:507–515
Freilinger G, Happak W, Burggasser G, Gruber H (1990) Histochemical mapping and fiber size analysis of mimic muscles. Plast Reconstruct Surg 86:422–428
Frueh BR, Felt DP, Wojno TH, Musch DC (1984) Treatment of blepharospasm with botulinum toxin: a preliminary report. Arch Opthalmol 102:1464–1468
Geller BD, Hallett M, Ravits JR (1989) Botulinum toxin therapy in hemifacial spasm: clinical and electrophysiologic studies. Muscle Nerve 12:716–722
Gordon G (1951) Observations upon the movements of the eyelids. Br J Ophthalmol 35:339–351
Gori Z (1972) Proliferations of the sarcoplasmic reticulum and T system in denervated muscle fibers. Virchows Arch 11:147–160
Gundersen CB (1980) The effects of botulinum toxin on the synthesis, storage and release of acetylcholine. Prog Neurobiol 14:99–119
Holds JB, Alderson K, Fogg SG, Anderson RL (1990) Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci 31:964–967
Holland RL, Brown MC (1981) Nerve growth in botulinum toxin poisoned muscles. Neuroscience 6:1167–1179
Horn AKE, Porter JD, Evinger C (1991) Effect of botulinum toxin A on the physiology and morphology of the orbicularis oculi muscle. Soc Neurosci Abstr 17:461
King WM, Yeaple RN, Metz H (1986) Orbital stiffness changes induced by injection of botulinum toxin into simian extraocular muscles. In: Keller EL, Zee DS (eds) Advances in the biosciences, vol 57. Adaptive processes in visual and oculomotor systems. Pergamon Press Oxford, pp 21–25
Kraft SP, Lang AE (1988) Cranial dystonia, blepharospasm, and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. Can Med Assoc J 139:837–844
Manning KA, Evinger C (1986) Different forms of blinks and their two-stage control. Exp Brain Res 64:579–588
Manning, KA, Evinger C, Sibony PA (1990) Eyelid movements before and after botulinum therapy in patients with lid spasm. Ann Neurol 28:653–660
McLoon SC, Wirtschafter JD (1991) Regional differences in the orbicularis oculi: conservation between species. J Neurol Sci 104:197–202
Monton CF, Silos I, Fernandez R, Lafarga M (1986) Laminated cytoplasmic bodies in Schwann cells and phagocytes: an ultrastructural and cytochemical study in normal and lead-damaged peripheral nervous system of the rat. J Submicrosc Cytol 18:153–159
Nelson CC, Blaivas M (1991) Orbicularis oculi muscle in children: Histologic and histochemical characteristics. Invest Ophthalmol Vis Sci 32:646–654
Porter JD, Baker RS (1992) Prenatal morphogenesis of primate extraocular muscle: neuromuscular junction formation and fiber type differentiation. Invest Ophthalmol Vis Sci 33:657–670
Porter JD, Burns LA, May PJ (1989) Morphological substrate for eyelid movements: innervation and structure of primate levator palpebrae superioris and orbicularis oculi muscles. J Comp Neurol 287:64–81
Porter JD, Strebeck S, Capra NF (1991) Botulinum-induced changes in monkey eyelid muscle: comparison with those seen in extraocular muscle. Arch Opthalmol 109:396–404
Rich MM, Lichtman JW (1989) In vivo visualization of pre- and postsynaptic changes during synapse elimination in reinnervated mouse muscle. J Neurosci 9:1781–1805
Robbins N, Polak J (1988) Filopodia, lamellipodia and retractions at mouse neuromuscular junctions. J Neurocytol 17:545–561
Robinson DA (1966) A method of measuring eye movement using a scleral search coil in a magnetic field. IEEE Trans Biomed Eng 10:137–145
Salviati G, Pierobon-Bormioli S, Betto R, Damiani E, Angelini C, Ringel SP, Salvatori S, Margreth A (1985) Tubular aggregates: sarcoplasmic reticulum origin, calcium storage ability, and functional implications. Muscle Nerve 8:299–306
Schantz EJ, Johnson EA (1992) Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 56:80–99
Scott AB, Kennedy RA, Stubbs HA (1985) A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 103:347–350
Shahani BT, Young RR (1973) Blink reflexes in orbicularis oculi. In: Desmedt JE (eds) New developments in electromyography and clinical neurophysiology, vol III. Karger, Basel, pp 641–648
Sibony PA, Evinger C, Manning KA (1991) Eyelid movements in facial paralysis. Arch Ophthalmol 109:1555–1561
Simpson LL (1986) Molecular pharmacology of botulinum toxin and tetanus toxin. Ann Rev Pharmacol Toxicol 26:427–453
Spencer RF, McNeer KW (1987) Botulinum toxin paralysis of adult monkey extraocular muscle: structural alterations in orbital, singly innervated muscle fibers. Arch Ophthalmol 105:1703–1711
Tågerud S, Libelius R, Thesleff S (1986) Effects of botulinum toxin induced muscle paralysis on endocytosis and lysosomal enzyme activities in mouse skeletal muscle. Pflügers Arch 407:275–278
Tonge DA (1974) Physiological characteristics of re-innervation of skeletal muscle in the mouse. J Physiol 241:141–153
Tsoy EA, Buckley EG, Dutton JJ (1985) Treatment of blepharospasm with botulinum toxin. Am J Ophthalmol 99:176–179
Tsujimoto T, Kuno M (1988) Calcitonin gene-related peptide prevents disuse-induced sprouting of rat motor nerve terminals. J Neurosci 8:3951–3957
Uemura-Sumi M, Manabe Y, Matsushima R, Mizuno N (1986) Correlation of the main peripheral branches of the facial nerve with the cytoarchitectonic subdivisions of the facial nucleus in the guinea pig. Anat Embryol 174:161–166
Valls-Sole J, Tolosa ES (1989) Blink reflex excitability cycle in hemifacial spasm. Neurology 39:1061–1066
Vaughn DW (1990) The effects of age on enzyme activities in the rat facial nucleus following axotomy: acetylcholine and cytochrome oxidase. Exp Neurol 109:224–236
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Horn, A.K.E., Porter, J.D. & Evinger, C. Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structúre physiology and lid kinematics. Exp Brain Res 96, 39–53 (1993). https://doi.org/10.1007/BF00230437
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00230437